Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-008513

Odonate Therapeutics, Inc. · ODT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Aaron I. Davis
Director · 10% Owner
Period of report
Mar 22, 2018
Accepted (ET)
Mar 26, 2018 · 6:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Mar 22, 2018P23,407$20.94A2,750,345ISee Footnote
Common StockF2Mar 23, 2018P42,943$23.96A2,793,288ISee Footnote
Common StockF2Mar 26, 2018P33,650$22.41A2,826,938ISee Footnote
Common StockF3holding———645,756D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses